Relx (LON:REL)‘s stock had its “buy” rating reaffirmed by stock analysts at Liberum Capital in a report issued on Monday. They presently have a GBX 1,750 ($23.73) target price on the stock. Liberum Capital’s price objective suggests a potential upside of 6.38% from the stock’s current price.
REL has been the subject of several other reports. Deutsche Bank reiterated a “hold” rating and set a GBX 1,515 ($20.55) price objective on shares of Relx in a research note on Friday, October 27th. Kepler Capital Markets upgraded Relx to a “buy” rating and increased their price objective for the stock from GBX 1,600 ($21.70) to GBX 1,990 ($26.99) in a research note on Monday, November 20th. Panmure Gordon reiterated a “hold” rating and set a GBX 1,550 ($21.02) price objective on shares of Relx in a research note on Friday, October 27th. Barclays reiterated an “overweight” rating and set a GBX 1,885 ($25.56) price objective on shares of Relx in a research note on Friday, October 27th. Finally, JPMorgan Chase & Co. increased their price objective on Relx from GBX 1,753 ($23.77) to GBX 1,905 ($25.83) and gave the stock an “overweight” rating in a research note on Thursday, December 7th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of GBX 1,694.53 ($22.98).
Relx (REL) opened at GBX 1,645 ($22.31) on Monday. The company has a market capitalization of $33,930.00 and a price-to-earnings ratio of 5,306.45. Relx has a 12-month low of GBX 1,397 ($18.94) and a 12-month high of GBX 1,784 ($24.19).
RELX PLC is a holding company, which holds interests in RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions.
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.